INTERACTION BETWEEN MOCLOBEMIDE AND ORAL TYRAMINE IN DEPRESSED-PATIENTS

被引：8

作者：

BURGESS, CD ^{[1
]}

MELLSOP, GW ^{[1
]}

机构：

[1] WELLINGTON SCH MED,DEPT PSYCHOL MED,WELLINGTON,NEW ZEALAND

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1989年 / 3卷 / 01期

关键词：

D O I：

10.1111/j.1472-8206.1989.tb00029.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：47 / 52

页数：6

共 7 条

[1]

DEPRADA M, 1982, MONOAMINE OXIDASE BA, P183

[2] ORAL ABSORPTION AND CONCENTRATION-EFFECT RELATIONSHIP OF TYRAMINE WITH AND WITHOUT CIMOXATONE, A TYPE-A SPECIFIC INHIBITOR OF MONOAMINE-OXIDASE [J].

DOLLERY, CT ;

BROWN, MJ ;

DAVIES, DS ;

LEWIS, PJ ;

STROLINBENEDETTI, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :651-662

[3]

GHOSE K, 1975, LANCET, V1, P1317

[4] EVIDENCE FOR A SPECIFIC MONOAMINE OXIDASE ASSOCIATED WITH SYMPATHETIC NERVES [J].

GORIDIS, C ;

NEFF, NH .

NEUROPHARMACOLOGY, 1971, 10 (05) :557-&

[5] MOCLOBEMIDE, A NEW REVERSIBLE MAO INHIBITOR INTERACTION WITH TYRAMINE AND TRICYCLIC ANTIDEPRESSANTS IN HEALTHY-VOLUNTEERS AND DEPRESSIVE PATIENTS [J].

KORN, A ;

EICHLER, HG ;

FISCHBACH, R ;

GASIC, S .

PSYCHOPHARMACOLOGY, 1986, 88 (02) :153-157

[6] ANTI-DEPRESSANT EFFECT OF RO 11-1163, A NEW MAO INHIBITOR [J].

STEFANIS, CN ;

ALEVIZOS, BH ;

PAPADIMITRIOU, GN .

INTERNATIONAL PHARMACOPSYCHIATRY, 1982, 17 (01) :43-48

[7]

1980, DIAGNOSTIC STATISTIC

← 1 →